29th Dec 2014 10:22
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi |
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii | Indivior PLC |
2 Reason for the notification (please tick the appropriate box or boxes): |
An acquisition or disposal of voting rights |
| |
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
| |
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
| |
An event changing the breakdown of voting rights |
| |
Other (please specify): | Reckitt Benckiser Group ("RB Group") demerger of the Reckitt Benckiser Pharmaceutical business; RB Group shareholders received one ordinary share in Indivior PLC for each ordinary share in RB Group held on 23 December 2014. | Yes |
3. Full name of person(s) subject to the notification obligation: iii | Massachusetts Financial Services Company |
4. Full name of shareholder(s) (if different from 3.):iv | MFS invests in securities of the issuer on behalf of its various mutual funds and institutional account clients. |
5. Date of the transaction and date on which the threshold is crossed or reached: v | 23 December 2014 |
6. Date on which issuer notified: | 24 December 2014 |
7. Threshold(s) that is/are crossed or reached: vi, vii | 5% |
8. Notified details:A: Voting rights attached to shares viii, ix
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation afterthe triggeringtransaction | |||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number ofvotingrights | % of votingrights x | |||||||
Direct | Direct xi | Indirect xii | Direct | Indirect | |||||||
GB00BRS65X63 | N/A | N/A |
|
| 39,878,835 |
| 5.5497% | ||||
B: Qualifying Financial Instruments | |||||||||||
Resulting situation after the triggering transaction | |||||||||||
Type of financialinstrument | Expirationdate xiii | Exercise/Conversion Period xiv | Number of votingrights that may beacquired if theinstrument isexercised/ converted. | % of votingrights | |||||||
|
|
|
|
| |||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||
Resulting situation after the triggering transaction | ||||||
Type of financialinstrument | Exerciseprice | Expirationdate xvii | Exercise/Conversionperiod xviii | Number of votingrights instrumentrefers to
| % of votingrights xix, xx
| |
Nominal | Delta | |||||
|
|
|
|
|
|
|
Total (A+B+C) | |
Number of voting rights | Percentage of voting rights |
39,878,835 | 5.5497% |
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi |
Entity Holding Percentage Held MFS Investment Management (LUX) S.A. (LUX) 1,743,939.00 0.2427% MFS Investment Management Canada Ltd 1,368,913.00 0.1905% MFS - Massachusetts Financial Services Company 18,000,835.00 2.5051% MFS Heritage Trust Company 373,575.00 0.0521% MFS Institutional Advisors, Inc. 8,773,415.00 1.2209% MFS International Singapore Pte. Ltd. 206,290.00 0.0287% MFS International (U.K.) Ltd. 6,448,819.00 0.8974% MFS Investment Management K.K. 2,963,049.00 0.4123%
Notifiable Interest 39,878,835 5.5497%
Shares Outstanding 718,577,616
|
Proxy Voting: | |
10. Name of the proxy holder: | N/A |
11. Number of voting rights proxy holder will cease to hold: | N/A |
12. Date on which proxy holder will cease to hold voting rights: | N/A |
13. Additional information: |
|
14. Contact name: |
|
15. Contact telephone number: |
|
Note: Annex should only be submitted to the FSA not the issuer |
Annex: Notification of major interests in share |
A: Identity of the persons or legal entity subject to the notification obligation
Full name(including legal form of legal entities) |
|
Contact address(registered office for legal entities) |
|
Phone number & email |
|
Other useful information(at least legal representative for legal persons) |
|
B: Identity of the notifier, if applicable
Full name |
|
Contact address |
|
Phone number & email |
|
Other useful information(e.g. functional relationship with the person or legal entity subject to the notification obligation) |
|
C: Additional information |
|
For notes on how to complete form TR-1 please see the FSA website.
Related Shares:
Indivior